Skip to main content
· 9/27/1999

Brumbaugh v. Sandoz Pharmaceutical Corp.

Citations

  • 77 F. Supp. 2d 1153
  • 1999 U.S. Dist. LEXIS 20824
  • 1999 WL 1104539

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • noting that the most significant analytical defect of case reports is that they “don’t isolate and investigate the effects of alternative causation agents... [tjhey reflect reported data, not scientific methodology.”
  • noting that the most significant analytical defect of case reports is that they “don’t isolate and investigate the effects of alternative causation agents, [t]hey reflect reported data, not scientific methodology”
  • excluding plaintiffs expert’s testimony regarding Parlodel® because, inter alia no proof was presented to support his “causal mechanism theory”
  • “Testimony extending general conclusions about ... drugs [similar to bromocriptine] does not meet Dau-bert’s requirement of reliability.”
  • “[hjere, the limited probative worth of Dr. Iffy’s testimony is outweighed by the substantial probability of misleading the jury so the evidence is inadmissible pursuant to Fed.R.Evid. 403”
  • \Testimony extending general conclusions about similar drugs does not meet Daubert's requirement of reliability.\

Source: CourtListener parenthetical corpus (CC0).

Judges: Molloy

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.